Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥675.7bn2023-04-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥239.1bn2023-10-01 → 2023-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥881.9bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥641.5bn2022-04-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥224.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥39.0bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥34.2bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥142.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥49.0bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥33.0bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥34.0bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥182.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥139.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥50.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥235.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥18.9bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥143.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥108.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥235.6bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥18.9bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥108.4bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥1.47Tat 2023-12-31Cons.Assets IFRS
Total assets¥1.51Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.39Tat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥718.2bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥867.5bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥749.9bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥641.2bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥605.6bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥749.9bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥640.1bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥604.5bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥348.6bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥169.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥211.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥12.9bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥98.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥54.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥391.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥58.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥37.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥240.8bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥143.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥112.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥191.592023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥15.842023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥113.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥85.122022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥191.152023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥15.812023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.082022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥85.042022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.62022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio51.1%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥29.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31¥83.6bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2023-04-01 → 2023-12-31¥971m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥16.2bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥68.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥15.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥110.7bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-12-31−¥917m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥48.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥157.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 747
ItemContextValueUnit
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember116317000000JPY
Equity IFRSCurrentQuarterInstant_jpcrp040300-q3r_E02272-000OtherComponentsOfCapitalRelatedToTheDisposalGroupHeldForSaleIFRSMember-JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember585999000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember749882000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember-JPY
Equity IFRSCurrentQuarterInstant749882000000JPY
Profit loss before tax IFRSPrior1YTDDuration139370000000JPY
Profit loss before tax IFRSCurrentYTDDuration33018000000JPY
Profit loss before tax from discontinued operations IFRSPrior1YTDDuration1934000000JPY
Profit loss before tax from discontinued operations IFRSCurrentYTDDuration348114000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration52313000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration49135000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration1311000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration42805000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-2870000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-1735000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration4533000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration4220000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSPrior1YTDDuration-15834000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSCurrentYTDDuration187000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-490000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration354000000JPY
Gain on transfer of ssd ope cf IFRSPrior1YTDDuration-JPY
Gain on transfer of ssd ope cf IFRSCurrentYTDDuration-349030000000JPY
Decrease increase in trade and other receivables ope cf IFRSPrior1YTDDuration2853000000JPY
Decrease increase in trade and other receivables ope cf IFRSCurrentYTDDuration13523000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-31354000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-20956000000JPY
Increase decrease in trade and other payables ope cf IFRSPrior1YTDDuration-2830000000JPY
Increase decrease in trade and other payables ope cf IFRSCurrentYTDDuration-6049000000JPY
Increase decrease in retirement benefit liability ope cf IFRSPrior1YTDDuration-1500000000JPY
Increase decrease in retirement benefit liability ope cf IFRSCurrentYTDDuration-2208000000JPY
Decrease increase in retirement benefit asset ope cf IFRSPrior1YTDDuration1156000000JPY
Decrease increase in retirement benefit asset ope cf IFRSCurrentYTDDuration-626000000JPY
Increase decrease in provisions ope cf IFRSPrior1YTDDuration-2333000000JPY
Increase decrease in provisions ope cf IFRSCurrentYTDDuration2378000000JPY
Other changes in working capital ope cf IFRSPrior1YTDDuration-9577000000JPY
Other changes in working capital ope cf IFRSCurrentYTDDuration13793000000JPY
Subtotal ope cf IFRSPrior1YTDDuration136682000000JPY
Subtotal ope cf IFRSCurrentYTDDuration126923000000JPY
Interest received ope cf IFRSPrior1YTDDuration2840000000JPY
Interest received ope cf IFRSCurrentYTDDuration1732000000JPY
Dividends received ope cf IFRSPrior1YTDDuration30000000JPY
Dividends received ope cf IFRSCurrentYTDDuration3000000JPY
Interest paid ope cf IFRSPrior1YTDDuration-4070000000JPY
Interest paid ope cf IFRSCurrentYTDDuration-3706000000JPY
Income taxes refund paid ope cf IFRSPrior1YTDDuration-80539000000JPY
Income taxes refund paid ope cf IFRSCurrentYTDDuration-137813000000JPY
Net cash provided by used in operating activities IFRSPrior1YTDDuration54943000000JPY
Net cash provided by used in operating activities IFRSCurrentYTDDuration-12861000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass